
About


EMA Clinical Data Publication Policy to Cover All New Marketing Authorization Applications, Line Extensions and Major Clinical Type II Variations Starting Q2 2025
EU Talking Life Sciences Audiocast: WHO Prequalification Procedures in Africa

UK HRA Consults on a New Model Investigator-Initiated Study Agreement

EMA announces €10 million of funding to support the establishment of the African Medicines Agency
EU Talking Life Sciences Audiocast: Supplementary Protection Certificates – What It Means for a Product to Be Protected by a Basic Patent in Force and Future Proposals in the EU
EU Talking Life Sciences Audiocast: Clinical Trial Transparency Requirements in the EU

EU Pharma Legislation Review Series: Unitary Supplementary Protection Certificates and Recast

EU Pharma Legislation Review Series: Bolar Exemption under Patent Rights
